Obesity is a complex and chronic disease that affects millions of people worldwide. It is associated with increased risk of various health complications, such as diabetes, cardiovascular disease, and cancer. However, the current treatment options for obesity are limited and often ineffective in the long term. Therefore, there is a great need for new and improved pharmacological therapies that can help people with obesity achieve and maintain a healthy weight.

Here is a brief overview of some of the current and emerging drugs for the treatment of obesity, and their mechanisms of action, efficacy, and safety.

Current Drugs for Obesity

There are currently five drugs approved by the FDA for the specific treatment of obesity. They are:

  • Orlistat: This drug works by inhibiting the enzyme that breaks down dietary fat, thus reducing the absorption of fat and calories from the gut. It can help people lose about 3% of their body weight over a year, but it also causes gastrointestinal side effects, such as oily stools, flatulence, and diarrhea⁹.
  • Lorcaserin: This drug works by activating the serotonin 2C receptor in the brain, which reduces appetite and increases satiety. It can help people lose about 5% of their body weight over a year, but it also carries a risk of cardiovascular and psychiatric adverse events, such as hypertension, headache, and depression⁹.
  • Phentermine/Topiramate: This combination drug works by stimulating the sympathetic nervous system and modulating the activity of certain neurotransmitters, such as norepinephrine, dopamine, and glutamate, which affect appetite and energy expenditure. It can help people lose about 10% of their body weight over a year, but it also causes side effects, such as insomnia, dry mouth, constipation, and cognitive impairment⁹.
  • Naltrexone/Bupropion: This combination drug works by blocking the opioid receptors and inhibiting the reuptake of dopamine and norepinephrine in the brain, which reduce food cravings and increase energy expenditure. It can help people lose about 6% of their body weight over a year, but it also causes side effects, such as nausea, vomiting, headache, and anxiety⁹.
  • Liraglutide: This drug works by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that is secreted by the gut after a meal and stimulates insulin secretion, inhibits glucagon secretion, and reduces appetite and gastric emptying. It can help people lose about 9% of their body weight over a year, but it also causes side effects, such as nausea, vomiting, diarrhea, and pancreatitis⁹.

Conclusion

Obesity is a serious and challenging disease that requires a comprehensive and individualized approach to management. Pharmacological therapy is one of the options that can help people with obesity achieve and maintain a healthy weight, along with lifestyle modifications, behavioral interventions, and surgical procedures. However, the current drugs for obesity are not effective or safe enough for everyone, and there is a need for more research and development of new and improved drugs that can target different mechanisms of obesity and offer better outcomes and fewer side effects. The emerging drugs for obesity are promising and exciting, but they also need more evidence and evaluation before they can be widely used and recommended.

I hope you found this post informative and useful. If you have any questions or comments, please feel free to share them below. Thank you for reading! 😊